Natural Product Sciences

  • 제9권1호
  • /
  • Pages.38-43
  • /
  • 2003
  • /
  • 1226-3907(pISSN)
  • /
  • 2288-9027(eISSN)
한국생약학회 (The Korean Society of Pharmacognosy)
권호 표지

Rhei Rhizoma and Chunghyuldan Inhibit Pancreatic Lipase

  • Yang, Hyung-Kil (College of Oriental Medicine, Kyung Hee University) ;
  • Kim, Young-Suk (College of Oriental Medicine, Kyung Hee University) ;
  • Bae, Hyung-Sup (College of Oriental Medicine, Kyung Hee University) ;
  • Cho, Ki-Ho (College of Oriental Medicine, Kyung Hee University) ;
  • Shin, Ji-Eun (College of Pharmacy, Kyung Hee University) ;
  • Kim, Nam-Jae (East-West Medical Research Institute, Kyung Hee University) ;
  • Kim, Dong-Hyun (College of Pharmacy and East-West Medical Research Institute, Kyung Hee University)
  • 발행 : 2003.03.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Pancreatic lipase-inhibitory activity of the rhizome of Rhei Rhizoma and its antihyperlipidemic activity were measured. Rhei Rhizoma inhibited pancreatic lipase with $IC_{50}$ value of 6.5 mg/ml (triolein as a substrate). Rhei Rhizoma significantly inhibited serum TG level in corn oil feeding-induced mice, and serum TG and cholesterol in Triton WR-1339-induced hyperlipidemic mice. However, Rhei Rhizoma did not show the hypolipidemic activity in high cholesterol diet-induced hyperlipidemic mice. When in vitro pancreatic lipase-inhibitory and in vivo antihyperlipidemic activities of Whangryunhaedoktang (WT) and Chunghyuldan (CD), which is consisted of ingredients of WT and Rhei Rhizoma, were measured, CD exhibited more potent inhibitory activities than WT. Therefore these results suggest that antihyperlipidemic activity of Rhei Rhizoma and CD may be more or less originated from the inhibition of pancreatic lipase.

키워드

참고문헌

  1. Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-5 (1974)
  2. Ballinger, A., Peikin, S. R., Orlistat: its current status as an antiobesity drug. Eur. J. Phannacol., 440, 109-117 (2002) https://doi.org/10.1016/S0014-2999(02)01422-X
  3. Carey, M. C, Small, D. M., Bliss, C. M., Lipid digestion and absorption. Annu. Rev. Physiol., 45, 651-677 (1983) https://doi.org/10.1146/annurev.ph.45.030183.003251
  4. Duhault, J., Boulanger, M., Beregi, L., Sicot, N., Bouvier, F. A new type of hyperlipidemic agent comparative assay in rats. Atherosclerosis. 23, 63-72 (1976) https://doi.org/10.1016/0021-9150(76)90118-0
  5. Han, L. K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T., Hayashi, T., Zheng, Y. N., Okuda, H. Antiobesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 25, 1459-1464 (2001) https://doi.org/10.1038/sj.ijo.0801747
  6. Hayakawa J, Noda N, Yamada S, Mikarni E, Uno K. Studies on physical and chemical quality evaluation of crude drugs preparations. III. Analysis of Gardenia fruits and its preparations. Yakugaku Zasshi. 105, 996-1000 (1985)
  7. Hong, N. D., Kim, J. W., Doo, H. K., Kim, N. J., Studies on the efficacy of combined preparation of crude drugs (V)-Effect of 'Whangryonhaedok-Tang' on the antiinflammatory, ileum of mice, blood pressure, blood glucose, total cholesterol and antibacterial activity. Kor. J. Phannacog. 13, 26-32 (1982)
  8. Junge, W., 'Methods of Enzymatic Analysis,' Vol. 4., ed. by Bergmeyer H. U., Verlag Chemie GmbH, Weinheim, 1984, pp. 15-25
  9. Kim, Y. S., Jung, E. A., Chang, J. C., Yang, H. K., Kim, N. J., Cho, C. H., Bae, H. S., Lee, K. S., Kim, D. H. Effect of Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. BioI. Pharm. Bull. 25, 1442-1445 (2002) https://doi.org/10.1248/bpb.25.1442
  10. Kusama, H., Nishiyama, M., Ikeda, S., Pharmacological investigation of bezafibrate, a hypolipidemic agent, (I). Effect of bezafibrate on normal and experimental hyperlipidemia in rats. Folia pharmacal. Japan, 92, 175-180 (1988) https://doi.org/10.1254/fpj.92.175
  11. Mainard, F., Madec, Y., Cholesterol, phospholipid and apo B composition of LDL; Comparison of precipitation and ultracentrifugation methods. Ann. BioI. Clin. 44, 618-623 (1986)
  12. Niiho, H., Yamazaki, T., Nakajima, Y., Itoh, H., Takeshi ,T., Kinjo, J., Nohara, T Pharmacological studies on Puerariae Flos. II. The effects of Puerariae Flos on alcohol-indue d unusual metabolism and experimental liver injury in mice. Yakugaku Zasshi. 110, 604-11 (1990)
  13. Ohshima, Y, Takahashi, K., Hiraga, Y., Shibata, S. Studies on the evaluation of Chinese drug preparations. Determination of sennosides in the drug preparation containing Rhubarb. Shoyakugaku Zasshi. 37, 217-222 (1983)
  14. Olsson, A. G., Lang, P. D., Vollmar, J., Effect of bezafibrate during 4,5 years of treatment of hyperlipidemia. Atheroscleosis, 55, 195-199 (1985) https://doi.org/10.1016/0021-9150(85)90098-X
  15. Raghavendra, M. P, Prakash, V.Phenylboronic acid - a potent inhibitor of lipase from Oryza stiva. J. Agric. Food Chem. 50, 6037-6041 (2002) https://doi.org/10.1021/jf0112926
  16. Sardesai, V. M., Mannig, J. A., The determination of triglycerides in plasma and tissues. Clin. Chem. 14, 156-158 (1968)
  17. Suenaga, T., Shirakawa, T., Harada, N., Tao, C., Yamasaki, M., Komatsu, H, Matsumoto,N., Kida, M., Kawamoto,Y., Murakami, Y., Kakamura, M., Mieno, H, Inoue, M., Kajiyama, G., Mechanism of protective effects of Ouren-Gedoku-To and San'ou-Syanshin-To on the gastric mucosa. Folia pharmacal japan. 98, 319-325 (1991) https://doi.org/10.1254/fpj.98.4_319
  18. The Korean Pharmacopia. 7th ed. pp. 721, 766, 778, 779, 781, 1997
  19. Yamamoto, M., Shimura, S., Itoh, Y., Ohsaka, T., Egawa, M., Inoue, S. Antiobesity effects of lipase inhibitor CT-II an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 24, 758-764 (2000) https://doi.org/10.1038/sj.ijo.0801222
  20. Yoshinaga, S., Kimura, M., Tanaka, A., Tomonaga, M., The effect of Kampa medicine 'Oren-gedoku-to' on clinical manifestations and cerebral blood flow in chronic stage of cerebrovascular diseases. J. Med. Pharm. Sco. WAKAN-YAKU, 9, 22-27 (1992)